1-(2-METHOXYPHENYL)CYCLOPROPANECARBONITRILE, 95.0%, 1g

7-Hydroxy-4-(3-trifluoromethylphenyl)coumarin, 95.0%, 5g

1-[(tert-Butoxy)carbonyl]-2,2-dimethylpiperidine-4-carboxylic acid, 98%, 10g

Colonne HPLC NUCLEODUR® 100-5 C8 ec, 150 mm, 4,6 mm, 1 pièce(s)

1-Bromo-3-fluoro-5-(methoxymethoxy)benzene, 95%, 1g

N,N-Diethyl-2,2,2-trifluoroacetamide>98.0%(GC)5g

4-(4-Bromophenyl)butan-1-amine, 95%, 500mg

Ethyl 3-(3-aminobenzamido)benzoate, 95%, 1g

DIPROPYL MALONATE, 95.0%, 100g

4-(3-Bromo-1-methyl-1H-1,2,4-triazol-5-yl) morpholine, 95.0%, 5g

1-(4-Methoxyphenyl)-6-(4-(2-methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide, 98%, 5mg

3-Chloro-n,2-dimethylbenzenesulfonamide, 95%, 500mg

Methyl 2-methanesulfonylpropanoate, 95%, 100mg